Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial

• Raphael Gottardo,

  Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Robert T. Bailer,

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Bette T. Korber,

  Affiliation Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Álamos, New Mexico, United States of America

  ⨯
• S. Gnanakaran,

  Affiliation Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Álamos, New Mexico, United States of America

  ⨯
• Joshua Phillips,

  Affiliation Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Álamos, New Mexico, United States of America

  ⨯
• Xiaoying Shen,

  Affiliation Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Georgia D. Tomaras,

  Affiliation Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Ellen Turk,

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Gregory Imholte,

  Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Larry Eckler,

  Affiliation JPT Peptide Technologies GmbH, Berlin, Germany

  ⨯
• Holger Wenschuh,

  Affiliation JPT Peptide Technologies GmbH, Berlin, Germany

  ⨯
• Johannes Zerweck,

  Affiliation JPT Peptide Technologies GmbH, Berlin, Germany

  ⨯
• Kelli Greene,

  Affiliation Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Hongmei Gao,

  Affiliation Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• Phillip W. Berman,

  Affiliation Baskin School of Engineering, University of California Santa Cruz, Santa Cruz, California, United States of America

  ⨯
• Donald Francis,

  Affiliation Global Solutions for Infectious Diseases, South San Francisco, California, United States of America

  ⨯
• Faruk Sinangil,

  Affiliation Global Solutions for Infectious Diseases, South San Francisco, California, United States of America

  ⨯
• Carter Lee,

  Affiliation Global Solutions for Infectious Diseases, South San Francisco, California, United States of America

  ⨯
• Sorachai Nitayaphan,

  Affiliation Department of Retrovirology, US Army Medical Component, AFRIMS, Bangkok, Thailand

  ⨯
• Supachai Rerks-Ngarm,

  Affiliation Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand

  ⨯
• Jaranit Kaewkungwal,

  Affiliation Center of Excellence for Biomedical and Public Health Informatics BIOPHICS, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

  ⨯
• Punnee Pitisuttithum,

  Affiliation Vaccine Trial Center and Department of Clinical Tropical Medicine, Mahidol University, Bangkok, Thailand

  ⨯
• James Tartaglia,

  Affiliation Department of Research and Development, Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America

  ⨯
• Merlin L. Robb,

  Affiliation US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Nelson L. Michael,

  Affiliation US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Jerome H. Kim,

  Affiliation US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America

  ⨯
• Susan Zolla-Pazner,

  Affiliations Veterans Affairs New York Harbor Healthcare System, New York, New York, United States of America, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Barton F. Haynes,

  Affiliation Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• John R. Mascola,

  Affiliation Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Steve Self,

  Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Peter Gilbert,

  Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
•  [ ... ],
• David C. Montefiori

  * E-mail: david.montefiori@duke.edu

  Affiliation Duke University Medical Center, Durham, North Carolina, United States of America

  ⨯
• [ view all ]
• [ view less ]